Liver Lineup: HDV Diagnosis, Bulevirtide, and the Delta Pipeline
In this episode of Liver Lineup: Updates and Unfiltered Insights, hosts Kimberly Brown, MD (Henry Ford Hospital), and Nancy Reau, MD (Rush University Medical Center), are joined by Tatyana Kushner, MD (Weill Cornell Medicine), to discuss hepatitis delta virus (HDV).
Topics covered:
Why fewer than 10% of HBsAg-positive patients have ever been tested for HDV — and why that needs to change
The diagnostic cascade from HDV antibody to HDV RNA, and barriers to reflex testing implementation
The recent FDA approval of bulevirtide (Livdelzi) for chronic HDV infection, including dosing, administration…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.